We conducted an immunohistochemical analysis to evaluate the immunoreactivities of anti-FBXO32, anti-TRIM63, and anti-FoxO3a markers involved in diabetic skeletal muscle atrophy. This evidence concerns the gene FOXO3 and muscle atrophy.